SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

9560	Companies
188851	Keywords
120589	Articles
100789	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 03/08/2025 at 19:00, 9 months 13 days ago

Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD
Positive pivotal data for Dupixent in bullous pemphigoid presented at AAD, showing significant disease remission and reduction in severity, itch, and medication use. Regulatory submissions under review in US and EU

Dupixent Type 2 Inflammation Bullous Pemphigoid AAD Sustained Remission
BRIEF

published on 02/25/2025 at 07:05, 9 months 24 days ago

Sarclisa Gains Approval in Japan for Multiple Myeloma Treatment

Multiple Myeloma Sarclisa Approval Sanofi Oncology Japan Healthcare IMROZ Study
BRIEF

published on 02/25/2025 at 07:05, 9 months 24 days ago

Sarclisa obtient l'approbation au Japon pour le traitement du myélome multiple

Myélome Multiple Étude IMROZ Approbation De Sarclisa Sanofi Oncologie Système De Santé Au Japon
PRESS RELEASE

published on 02/25/2025 at 07:00, 9 months 24 days ago

Press Release: Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma
Sarclisa approved in Japan for newly diagnosed multiple myeloma patients, offering new treatment options based on positive IMROZ phase 3 study results

Oncology Japan Multiple Myeloma Sarclisa IMROZ Study
PRESS RELEASE

published on 02/24/2025 at 21:27, 9 months 25 days ago

Sanofi : Déclaration des transactions sur actions propres
PRESS RELEASE

published on 02/24/2025 at 21:27, 9 months 25 days ago

Sanofi: Disclosure of trading in own shares
BRIEF

published on 02/22/2025 at 08:35, 9 months 27 days ago

Sanofi-Teva : Promesses du Duvakitug pour les Maladies Inflammatoires de l'Intestin

Maladie De Crohn Colite Ulcéreuse Duvakitug RELIEVE UCCD Sanofi-Teva
BRIEF

published on 02/22/2025 at 08:35, 9 months 27 days ago

Sanofi-Teva: Duvakitug Promises for Inflammatory Bowel Diseases

Ulcerative Colitis Crohn's Disease Duvakitug RELIEVE UCCD Sanofi-Teva
PRESS RELEASE

published on 02/22/2025 at 08:30, 9 months 27 days ago

Communiqué de presse : ECCO 2025 : de nouvelles données sur le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de la maladie de Crohn
Nouvelles données sur duvakitug présentées par Sanofi et Teva pour traiter colite ulcéreuse et maladie de Crohn au Congrès ECCO 2025, Berlin

Maladie De Crohn Sanofi Colite Ulcéreuse Teva Duvakitug
PRESS RELEASE

published on 02/22/2025 at 08:30, 9 months 27 days ago

Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease
Sanofi and Teva Pharmaceuticals present new detailed data from the RELIEVE UCCD study on duvakitug's efficacy in ulcerative colitis and Crohn's disease at ECCO 2025, demonstrating potential for phase 3 program in H2 2025

Ulcerative Colitis Sanofi Teva Pharmaceuticals Crohn's Disease RELIEVE UCCD Study

Accesswire

Published on 12/20/2025 at 00:30, 1 day 21 hours ago

Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 1 day 23 hours ago

GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 2 days 3 hours ago

Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 2 days 7 hours ago

Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 2 days 8 hours ago

Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF

View all ACCESSWIRE

EQS Group

Published on 12/21/2025 at 08:55, 12 hours 46 minutes ago

Vantage Markets recognised for real-time threat intelligence collaboration with Trend Micro
Published on 12/20/2025 at 16:45, 1 day 4 hours ago

Shanghai Electric Powers Up Iraq's Energy Future with Major 625MW Efficiency Upgrade
Published on 12/20/2025 at 10:05, 1 day 11 hours ago

FITUR 2026 highlights the strong synergies between Germany and Spain
Published on 12/19/2025 at 22:03, 1 day 23 hours ago

EAMD: Trading resumes on the Düsseldorf Stock Exchange, lawsuit filed by minority shareholders dismissed, capital increase for investments in drone projects in the defense tech sector
Published on 12/19/2025 at 21:40, 2 days ago

IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries

Les Echos

Published on 12/19/2025 at 21:57, 1 day 23 hours ago

Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 2 days 13 hours ago

Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 2 days 13 hours ago

Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 2 days 14 hours ago

EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 2 days 14 hours ago

EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION

View all LES ECHOS COMFI WIRE